Health Ministry moots Centre or state bodies be empowered to regulate drugs, cosmetics manufacture
FirstpostThe draft New Drugs, Medical Devices and Cosmetics Bill, 2023, has a separate chapter on AYUSH medicines, proposing for the first time to regulate Sowa Rigpa and homoeopathy. The latest draft of the New Drugs, Medical Devices and Cosmetics Bill, 2023, which seeks to replace the Drugs and Cosmetics Act of 1940, is yet to be approved by the Cabinet. “Notwithstanding, anything contained in this Act, the Central Licensing Authority or the Central Drugs, Medical Devices and Cosmetics Regulatory Authority may in public interest, abbreviate, defer or waive such pre-clinical and clinical data requirements for approval of new drug or clinical trials of new drug, investigational new drug or approval of medical device or clinical investigation of investigational medical device… taking into account its severity, rarity, un-met medical need, emergency, extreme urgency,” the draft bill read. The draft New Drugs, Medical Devices and Cosmetics Bill was placed in the public domain last year, seeking feedback from stakeholders.